[Immunotherapy] CD28 is a critical target for PD-1 blockade

PD-1–targeted therapies have been a breakthrough for treating certain tumors and can rejuvenate T cells to unleash the anticancer immune response (see the Perspective by Clouthier a – [Read More]

Source: This Week in Science - March 31, 2017 Category: Science Authors: Priscilla N. Kelly Tags: Immunotherapy Source Type: research